BioNTech SE (BNTX) Other Non-Current Liabilities (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Other Non-Current Liabilities data on file, last reported at $169.1 million in Q4 2025.

• For the quarter ending Q4 2025, Other Non-Current Liabilities rose 9.31% year-over-year to $169.1 million; the trailing twelve-month figure through Dec 2025 stood at $169.1 million (up 9.31% YoY), and the FY2025 full-year result was $164.2 million, up 6.09% from the prior year.
• Other Non-Current Liabilities declined to $169.1 million in Q4 2025, from $247.3 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $803.3 million in Q3 2024 to a low of $76.6 million in Q1 2021.
• A 5-year average of $261.2 million and a median of $229.4 million in 2021 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities surged 3125.58% in 2021 and plunged 69.22% in 2025, its largest moves.
• Tracing BNTX's Other Non-Current Liabilities over 5 years: stood at $211.5 million in 2021, then surged by 77.12% to $374.6 million in 2022, then declined by 22.66% to $289.8 million in 2023, then tumbled by 46.6% to $154.7 million in 2024, then gained by 9.31% to $169.1 million in 2025.
• Business Quant data shows BNTX's Other Non-Current Liabilities at $169.1 million in Q4 2025, $247.3 million in Q3 2025, and $164.8 million in Q2 2025.